Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Customers agree to comply with all terms of service
PubMed Brzoska, T., Bohm, M., Lugering, A., Loser, K., Luger, T.A
A 12-week trial showed that subjects receiving 1 mg per day of AOD 9604 lost an average of 2.6 kilograms compared to 0.8 kilograms in the placebo group
Tirzepatide represents a dual agonist, activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may explain its particularly robust weight loss effects
Low Starting Amount Amount per injection: 2.5 mg 50 units (0.50 mL) on a U-100 insulin syringe Frequency: Once daily, under the skin (subcutaneous) Cycle length: One 5 mg vial = 2 days at the starting amount Sources: [1] Selective small-molecule inhibitors of NNMT reverse high-fat-diet-induced obesity in mice PubMed
US$ 21.25
US$ 29.70
US$ 28.71
US$ 29.23
US$ 24.71
US$ 23.18
